nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2C9—Tamoxifen—pancreatic cancer	0.1	0.262	CbGbCtD
Flecainide—CYP2D6—Tamoxifen—pancreatic cancer	0.0918	0.24	CbGbCtD
Flecainide—CYP2D6—Erlotinib—pancreatic cancer	0.0781	0.204	CbGbCtD
Flecainide—CYP2C9—Fluorouracil—pancreatic cancer	0.074	0.193	CbGbCtD
Flecainide—CYP2D6—Doxorubicin—pancreatic cancer	0.0385	0.101	CbGbCtD
Flecainide—Somnolence—Fluorouracil—pancreatic cancer	0.000763	0.00124	CcSEcCtD
Flecainide—Decreased appetite—Gemcitabine—pancreatic cancer	0.000759	0.00123	CcSEcCtD
Flecainide—Dyspepsia—Fluorouracil—pancreatic cancer	0.000756	0.00122	CcSEcCtD
Flecainide—Nausea—Tamoxifen—pancreatic cancer	0.000755	0.00122	CcSEcCtD
Flecainide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000754	0.00122	CcSEcCtD
Flecainide—Fatigue—Gemcitabine—pancreatic cancer	0.000753	0.00122	CcSEcCtD
Flecainide—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000748	0.00121	CcSEcCtD
Flecainide—Constipation—Gemcitabine—pancreatic cancer	0.000747	0.00121	CcSEcCtD
Flecainide—Pain—Gemcitabine—pancreatic cancer	0.000747	0.00121	CcSEcCtD
Flecainide—Nausea—Erlotinib—pancreatic cancer	0.000747	0.00121	CcSEcCtD
Flecainide—Decreased appetite—Fluorouracil—pancreatic cancer	0.000746	0.00121	CcSEcCtD
Flecainide—Diarrhoea—Sunitinib—pancreatic cancer	0.000745	0.00121	CcSEcCtD
Flecainide—Dysgeusia—Docetaxel—pancreatic cancer	0.000744	0.0012	CcSEcCtD
Flecainide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000741	0.0012	CcSEcCtD
Flecainide—Ataxia—Doxorubicin—pancreatic cancer	0.00074	0.0012	CcSEcCtD
Flecainide—Feeling abnormal—Irinotecan—pancreatic cancer	0.000739	0.0012	CcSEcCtD
Flecainide—Pain—Fluorouracil—pancreatic cancer	0.000734	0.00119	CcSEcCtD
Flecainide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000733	0.00119	CcSEcCtD
Flecainide—Dizziness—Sunitinib—pancreatic cancer	0.00072	0.00117	CcSEcCtD
Flecainide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00072	0.00117	CcSEcCtD
Flecainide—Angina pectoris—Epirubicin—pancreatic cancer	0.000716	0.00116	CcSEcCtD
Flecainide—Abdominal pain—Irinotecan—pancreatic cancer	0.000709	0.00115	CcSEcCtD
Flecainide—Body temperature increased—Irinotecan—pancreatic cancer	0.000709	0.00115	CcSEcCtD
Flecainide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000708	0.00115	CcSEcCtD
Flecainide—Vomiting—Sunitinib—pancreatic cancer	0.000692	0.00112	CcSEcCtD
Flecainide—Body temperature increased—Gemcitabine—pancreatic cancer	0.00069	0.00112	CcSEcCtD
Flecainide—Dysuria—Epirubicin—pancreatic cancer	0.000687	0.00111	CcSEcCtD
Flecainide—Rash—Sunitinib—pancreatic cancer	0.000686	0.00111	CcSEcCtD
Flecainide—Dermatitis—Sunitinib—pancreatic cancer	0.000686	0.00111	CcSEcCtD
Flecainide—Urticaria—Fluorouracil—pancreatic cancer	0.000682	0.00111	CcSEcCtD
Flecainide—Headache—Sunitinib—pancreatic cancer	0.000682	0.0011	CcSEcCtD
Flecainide—Syncope—Docetaxel—pancreatic cancer	0.000681	0.0011	CcSEcCtD
Flecainide—Leukopenia—Docetaxel—pancreatic cancer	0.00068	0.0011	CcSEcCtD
Flecainide—Body temperature increased—Fluorouracil—pancreatic cancer	0.000679	0.0011	CcSEcCtD
Flecainide—Palpitations—Docetaxel—pancreatic cancer	0.000671	0.00109	CcSEcCtD
Flecainide—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000671	0.00109	CcSEcCtD
Flecainide—Loss of consciousness—Docetaxel—pancreatic cancer	0.000667	0.00108	CcSEcCtD
Flecainide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000663	0.00107	CcSEcCtD
Flecainide—Cough—Docetaxel—pancreatic cancer	0.000663	0.00107	CcSEcCtD
Flecainide—Angina pectoris—Doxorubicin—pancreatic cancer	0.000662	0.00107	CcSEcCtD
Flecainide—Pneumonia—Epirubicin—pancreatic cancer	0.000659	0.00107	CcSEcCtD
Flecainide—Convulsion—Docetaxel—pancreatic cancer	0.000658	0.00107	CcSEcCtD
Flecainide—Hypertension—Docetaxel—pancreatic cancer	0.000656	0.00106	CcSEcCtD
Flecainide—Myalgia—Docetaxel—pancreatic cancer	0.000646	0.00105	CcSEcCtD
Flecainide—Chest pain—Docetaxel—pancreatic cancer	0.000646	0.00105	CcSEcCtD
Flecainide—Arthralgia—Docetaxel—pancreatic cancer	0.000646	0.00105	CcSEcCtD
Flecainide—Nausea—Sunitinib—pancreatic cancer	0.000646	0.00105	CcSEcCtD
Flecainide—Renal failure—Epirubicin—pancreatic cancer	0.000644	0.00104	CcSEcCtD
Flecainide—Asthenia—Irinotecan—pancreatic cancer	0.000643	0.00104	CcSEcCtD
Flecainide—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000642	0.00104	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000642	0.00104	CcSEcCtD
Flecainide—Jaundice—Epirubicin—pancreatic cancer	0.000639	0.00103	CcSEcCtD
Flecainide—Dysuria—Doxorubicin—pancreatic cancer	0.000636	0.00103	CcSEcCtD
Flecainide—Dry mouth—Docetaxel—pancreatic cancer	0.000632	0.00102	CcSEcCtD
Flecainide—Asthenia—Gemcitabine—pancreatic cancer	0.000627	0.00102	CcSEcCtD
Flecainide—Haematuria—Epirubicin—pancreatic cancer	0.000625	0.00101	CcSEcCtD
Flecainide—Confusional state—Docetaxel—pancreatic cancer	0.000625	0.00101	CcSEcCtD
Flecainide—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000621	0.00101	CcSEcCtD
Flecainide—Oedema—Docetaxel—pancreatic cancer	0.00062	0.001	CcSEcCtD
Flecainide—Pruritus—Gemcitabine—pancreatic cancer	0.000618	0.001	CcSEcCtD
Flecainide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000614	0.000994	CcSEcCtD
Flecainide—Diarrhoea—Irinotecan—pancreatic cancer	0.000613	0.000994	CcSEcCtD
Flecainide—Agranulocytosis—Epirubicin—pancreatic cancer	0.000612	0.000991	CcSEcCtD
Flecainide—Pneumonia—Doxorubicin—pancreatic cancer	0.00061	0.000988	CcSEcCtD
Flecainide—Shock—Docetaxel—pancreatic cancer	0.00061	0.000988	CcSEcCtD
Flecainide—Nervous system disorder—Docetaxel—pancreatic cancer	0.000608	0.000985	CcSEcCtD
Flecainide—Pruritus—Fluorouracil—pancreatic cancer	0.000607	0.000984	CcSEcCtD
Flecainide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000607	0.000983	CcSEcCtD
Flecainide—Tachycardia—Docetaxel—pancreatic cancer	0.000605	0.00098	CcSEcCtD
Flecainide—Skin disorder—Docetaxel—pancreatic cancer	0.000602	0.000975	CcSEcCtD
Flecainide—Bradycardia—Epirubicin—pancreatic cancer	0.000599	0.00097	CcSEcCtD
Flecainide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000597	0.000968	CcSEcCtD
Flecainide—Renal failure—Doxorubicin—pancreatic cancer	0.000596	0.000966	CcSEcCtD
Flecainide—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000594	0.000963	CcSEcCtD
Flecainide—Dizziness—Irinotecan—pancreatic cancer	0.000593	0.00096	CcSEcCtD
Flecainide—Jaundice—Doxorubicin—pancreatic cancer	0.000591	0.000958	CcSEcCtD
Flecainide—Anorexia—Docetaxel—pancreatic cancer	0.000591	0.000957	CcSEcCtD
Flecainide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000587	0.000952	CcSEcCtD
Flecainide—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000585	0.000948	CcSEcCtD
Flecainide—Hypotension—Docetaxel—pancreatic cancer	0.000579	0.000938	CcSEcCtD
Flecainide—Haematuria—Doxorubicin—pancreatic cancer	0.000578	0.000937	CcSEcCtD
Flecainide—Vomiting—Irinotecan—pancreatic cancer	0.00057	0.000923	CcSEcCtD
Flecainide—Dizziness—Fluorouracil—pancreatic cancer	0.000568	0.00092	CcSEcCtD
Flecainide—Visual impairment—Epirubicin—pancreatic cancer	0.000567	0.000919	CcSEcCtD
Flecainide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000566	0.000917	CcSEcCtD
Flecainide—Rash—Irinotecan—pancreatic cancer	0.000565	0.000916	CcSEcCtD
Flecainide—Dermatitis—Irinotecan—pancreatic cancer	0.000565	0.000915	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000565	0.000915	CcSEcCtD
Flecainide—Headache—Irinotecan—pancreatic cancer	0.000562	0.00091	CcSEcCtD
Flecainide—Insomnia—Docetaxel—pancreatic cancer	0.00056	0.000908	CcSEcCtD
Flecainide—Paraesthesia—Docetaxel—pancreatic cancer	0.000556	0.000902	CcSEcCtD
Flecainide—Vomiting—Gemcitabine—pancreatic cancer	0.000555	0.0009	CcSEcCtD
Flecainide—Bradycardia—Doxorubicin—pancreatic cancer	0.000554	0.000898	CcSEcCtD
Flecainide—Dyspnoea—Docetaxel—pancreatic cancer	0.000552	0.000895	CcSEcCtD
Flecainide—Somnolence—Docetaxel—pancreatic cancer	0.000551	0.000893	CcSEcCtD
Flecainide—Rash—Gemcitabine—pancreatic cancer	0.000551	0.000892	CcSEcCtD
Flecainide—Dermatitis—Gemcitabine—pancreatic cancer	0.00055	0.000891	CcSEcCtD
Flecainide—Eye disorder—Epirubicin—pancreatic cancer	0.00055	0.000891	CcSEcCtD
Flecainide—Tinnitus—Epirubicin—pancreatic cancer	0.000549	0.000889	CcSEcCtD
Flecainide—Headache—Gemcitabine—pancreatic cancer	0.000547	0.000886	CcSEcCtD
Flecainide—Flushing—Epirubicin—pancreatic cancer	0.000546	0.000885	CcSEcCtD
Flecainide—Vomiting—Fluorouracil—pancreatic cancer	0.000546	0.000884	CcSEcCtD
Flecainide—Dyspepsia—Docetaxel—pancreatic cancer	0.000545	0.000884	CcSEcCtD
Flecainide—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000542	0.000878	CcSEcCtD
Flecainide—Rash—Fluorouracil—pancreatic cancer	0.000541	0.000877	CcSEcCtD
Flecainide—Dermatitis—Fluorouracil—pancreatic cancer	0.000541	0.000876	CcSEcCtD
Flecainide—Decreased appetite—Docetaxel—pancreatic cancer	0.000539	0.000873	CcSEcCtD
Flecainide—Headache—Fluorouracil—pancreatic cancer	0.000538	0.000871	CcSEcCtD
Flecainide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000535	0.000867	CcSEcCtD
Flecainide—Fatigue—Docetaxel—pancreatic cancer	0.000534	0.000866	CcSEcCtD
Flecainide—Nausea—Irinotecan—pancreatic cancer	0.000532	0.000863	CcSEcCtD
Flecainide—Immune system disorder—Epirubicin—pancreatic cancer	0.000531	0.000861	CcSEcCtD
Flecainide—Pain—Docetaxel—pancreatic cancer	0.00053	0.000859	CcSEcCtD
Flecainide—Constipation—Docetaxel—pancreatic cancer	0.00053	0.000859	CcSEcCtD
Flecainide—Visual impairment—Doxorubicin—pancreatic cancer	0.000525	0.00085	CcSEcCtD
Flecainide—Alopecia—Epirubicin—pancreatic cancer	0.00052	0.000842	CcSEcCtD
Flecainide—Nausea—Gemcitabine—pancreatic cancer	0.000519	0.00084	CcSEcCtD
Flecainide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000511	0.000827	CcSEcCtD
Flecainide—Nausea—Fluorouracil—pancreatic cancer	0.00051	0.000826	CcSEcCtD
Flecainide—Eye disorder—Doxorubicin—pancreatic cancer	0.000509	0.000824	CcSEcCtD
Flecainide—Tinnitus—Doxorubicin—pancreatic cancer	0.000508	0.000822	CcSEcCtD
Flecainide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000507	0.000821	CcSEcCtD
Flecainide—Flushing—Doxorubicin—pancreatic cancer	0.000505	0.000819	CcSEcCtD
Flecainide—Flatulence—Epirubicin—pancreatic cancer	0.000505	0.000818	CcSEcCtD
Flecainide—Tension—Epirubicin—pancreatic cancer	0.000503	0.000814	CcSEcCtD
Flecainide—Dysgeusia—Epirubicin—pancreatic cancer	0.000502	0.000813	CcSEcCtD
Flecainide—Nervousness—Epirubicin—pancreatic cancer	0.000497	0.000806	CcSEcCtD
Flecainide—Immune system disorder—Doxorubicin—pancreatic cancer	0.000492	0.000797	CcSEcCtD
Flecainide—Abdominal pain—Docetaxel—pancreatic cancer	0.00049	0.000794	CcSEcCtD
Flecainide—Body temperature increased—Docetaxel—pancreatic cancer	0.00049	0.000794	CcSEcCtD
Flecainide—Vision blurred—Epirubicin—pancreatic cancer	0.000483	0.000782	CcSEcCtD
Flecainide—Alopecia—Doxorubicin—pancreatic cancer	0.000481	0.000779	CcSEcCtD
Flecainide—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000475	0.00077	CcSEcCtD
Flecainide—Flatulence—Doxorubicin—pancreatic cancer	0.000467	0.000757	CcSEcCtD
Flecainide—Tension—Doxorubicin—pancreatic cancer	0.000465	0.000753	CcSEcCtD
Flecainide—Dysgeusia—Doxorubicin—pancreatic cancer	0.000464	0.000752	CcSEcCtD
Flecainide—Malaise—Epirubicin—pancreatic cancer	0.000462	0.000748	CcSEcCtD
Flecainide—Nervousness—Doxorubicin—pancreatic cancer	0.00046	0.000746	CcSEcCtD
Flecainide—Vertigo—Epirubicin—pancreatic cancer	0.00046	0.000745	CcSEcCtD
Flecainide—Syncope—Epirubicin—pancreatic cancer	0.000459	0.000744	CcSEcCtD
Flecainide—Leukopenia—Epirubicin—pancreatic cancer	0.000458	0.000743	CcSEcCtD
Flecainide—Palpitations—Epirubicin—pancreatic cancer	0.000453	0.000733	CcSEcCtD
Flecainide—Loss of consciousness—Epirubicin—pancreatic cancer	0.00045	0.000729	CcSEcCtD
Flecainide—Cough—Epirubicin—pancreatic cancer	0.000447	0.000724	CcSEcCtD
Flecainide—Vision blurred—Doxorubicin—pancreatic cancer	0.000447	0.000724	CcSEcCtD
Flecainide—Asthenia—Docetaxel—pancreatic cancer	0.000445	0.00072	CcSEcCtD
Flecainide—Convulsion—Epirubicin—pancreatic cancer	0.000444	0.000719	CcSEcCtD
Flecainide—Hypertension—Epirubicin—pancreatic cancer	0.000442	0.000716	CcSEcCtD
Flecainide—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00044	0.000712	CcSEcCtD
Flecainide—Pruritus—Docetaxel—pancreatic cancer	0.000438	0.00071	CcSEcCtD
Flecainide—Chest pain—Epirubicin—pancreatic cancer	0.000436	0.000706	CcSEcCtD
Flecainide—Arthralgia—Epirubicin—pancreatic cancer	0.000436	0.000706	CcSEcCtD
Flecainide—Myalgia—Epirubicin—pancreatic cancer	0.000436	0.000706	CcSEcCtD
Flecainide—Anxiety—Epirubicin—pancreatic cancer	0.000435	0.000704	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000433	0.000702	CcSEcCtD
Flecainide—Discomfort—Epirubicin—pancreatic cancer	0.000431	0.000698	CcSEcCtD
Flecainide—Malaise—Doxorubicin—pancreatic cancer	0.000427	0.000692	CcSEcCtD
Flecainide—Dry mouth—Epirubicin—pancreatic cancer	0.000426	0.000691	CcSEcCtD
Flecainide—Vertigo—Doxorubicin—pancreatic cancer	0.000426	0.00069	CcSEcCtD
Flecainide—Syncope—Doxorubicin—pancreatic cancer	0.000425	0.000689	CcSEcCtD
Flecainide—Leukopenia—Doxorubicin—pancreatic cancer	0.000424	0.000687	CcSEcCtD
Flecainide—Diarrhoea—Docetaxel—pancreatic cancer	0.000424	0.000687	CcSEcCtD
Flecainide—Confusional state—Epirubicin—pancreatic cancer	0.000421	0.000683	CcSEcCtD
Flecainide—Palpitations—Doxorubicin—pancreatic cancer	0.000419	0.000678	CcSEcCtD
Flecainide—Oedema—Epirubicin—pancreatic cancer	0.000418	0.000677	CcSEcCtD
Flecainide—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000417	0.000675	CcSEcCtD
Flecainide—Cough—Doxorubicin—pancreatic cancer	0.000414	0.00067	CcSEcCtD
Flecainide—Shock—Epirubicin—pancreatic cancer	0.000411	0.000666	CcSEcCtD
Flecainide—Convulsion—Doxorubicin—pancreatic cancer	0.000411	0.000665	CcSEcCtD
Flecainide—Nervous system disorder—Epirubicin—pancreatic cancer	0.00041	0.000664	CcSEcCtD
Flecainide—Dizziness—Docetaxel—pancreatic cancer	0.00041	0.000664	CcSEcCtD
Flecainide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000409	0.000663	CcSEcCtD
Flecainide—Hypertension—Doxorubicin—pancreatic cancer	0.000409	0.000663	CcSEcCtD
Flecainide—Tachycardia—Epirubicin—pancreatic cancer	0.000408	0.000661	CcSEcCtD
Flecainide—Skin disorder—Epirubicin—pancreatic cancer	0.000406	0.000658	CcSEcCtD
Flecainide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000404	0.000655	CcSEcCtD
Flecainide—Chest pain—Doxorubicin—pancreatic cancer	0.000403	0.000654	CcSEcCtD
Flecainide—Myalgia—Doxorubicin—pancreatic cancer	0.000403	0.000654	CcSEcCtD
Flecainide—Arthralgia—Doxorubicin—pancreatic cancer	0.000403	0.000654	CcSEcCtD
Flecainide—Anxiety—Doxorubicin—pancreatic cancer	0.000402	0.000651	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000401	0.000649	CcSEcCtD
Flecainide—Discomfort—Doxorubicin—pancreatic cancer	0.000399	0.000646	CcSEcCtD
Flecainide—Anorexia—Epirubicin—pancreatic cancer	0.000398	0.000646	CcSEcCtD
Flecainide—Dry mouth—Doxorubicin—pancreatic cancer	0.000395	0.000639	CcSEcCtD
Flecainide—Vomiting—Docetaxel—pancreatic cancer	0.000394	0.000638	CcSEcCtD
Flecainide—Rash—Docetaxel—pancreatic cancer	0.000391	0.000633	CcSEcCtD
Flecainide—Hypotension—Epirubicin—pancreatic cancer	0.000391	0.000633	CcSEcCtD
Flecainide—Dermatitis—Docetaxel—pancreatic cancer	0.00039	0.000632	CcSEcCtD
Flecainide—Confusional state—Doxorubicin—pancreatic cancer	0.00039	0.000632	CcSEcCtD
Flecainide—Headache—Docetaxel—pancreatic cancer	0.000388	0.000629	CcSEcCtD
Flecainide—Oedema—Doxorubicin—pancreatic cancer	0.000387	0.000627	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000381	0.000617	CcSEcCtD
Flecainide—Shock—Doxorubicin—pancreatic cancer	0.000381	0.000616	CcSEcCtD
Flecainide—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000379	0.000614	CcSEcCtD
Flecainide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000379	0.000614	CcSEcCtD
Flecainide—Insomnia—Epirubicin—pancreatic cancer	0.000378	0.000612	CcSEcCtD
Flecainide—Tachycardia—Doxorubicin—pancreatic cancer	0.000377	0.000612	CcSEcCtD
Flecainide—Skin disorder—Doxorubicin—pancreatic cancer	0.000376	0.000609	CcSEcCtD
Flecainide—Paraesthesia—Epirubicin—pancreatic cancer	0.000375	0.000608	CcSEcCtD
Flecainide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000374	0.000606	CcSEcCtD
Flecainide—Dyspnoea—Epirubicin—pancreatic cancer	0.000373	0.000604	CcSEcCtD
Flecainide—Somnolence—Epirubicin—pancreatic cancer	0.000372	0.000602	CcSEcCtD
Flecainide—Anorexia—Doxorubicin—pancreatic cancer	0.000369	0.000597	CcSEcCtD
Flecainide—Nausea—Docetaxel—pancreatic cancer	0.000368	0.000596	CcSEcCtD
Flecainide—Dyspepsia—Epirubicin—pancreatic cancer	0.000368	0.000596	CcSEcCtD
Flecainide—Decreased appetite—Epirubicin—pancreatic cancer	0.000363	0.000589	CcSEcCtD
Flecainide—Hypotension—Doxorubicin—pancreatic cancer	0.000361	0.000586	CcSEcCtD
Flecainide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000361	0.000585	CcSEcCtD
Flecainide—Fatigue—Epirubicin—pancreatic cancer	0.00036	0.000584	CcSEcCtD
Flecainide—Pain—Epirubicin—pancreatic cancer	0.000357	0.000579	CcSEcCtD
Flecainide—Constipation—Epirubicin—pancreatic cancer	0.000357	0.000579	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000352	0.000571	CcSEcCtD
Flecainide—Insomnia—Doxorubicin—pancreatic cancer	0.00035	0.000567	CcSEcCtD
Flecainide—Paraesthesia—Doxorubicin—pancreatic cancer	0.000347	0.000563	CcSEcCtD
Flecainide—Dyspnoea—Doxorubicin—pancreatic cancer	0.000345	0.000559	CcSEcCtD
Flecainide—Feeling abnormal—Epirubicin—pancreatic cancer	0.000344	0.000558	CcSEcCtD
Flecainide—Somnolence—Doxorubicin—pancreatic cancer	0.000344	0.000557	CcSEcCtD
Flecainide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000342	0.000554	CcSEcCtD
Flecainide—Dyspepsia—Doxorubicin—pancreatic cancer	0.00034	0.000552	CcSEcCtD
Flecainide—Decreased appetite—Doxorubicin—pancreatic cancer	0.000336	0.000545	CcSEcCtD
Flecainide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000334	0.000541	CcSEcCtD
Flecainide—Fatigue—Doxorubicin—pancreatic cancer	0.000333	0.00054	CcSEcCtD
Flecainide—Urticaria—Epirubicin—pancreatic cancer	0.000332	0.000538	CcSEcCtD
Flecainide—Pain—Doxorubicin—pancreatic cancer	0.000331	0.000536	CcSEcCtD
Flecainide—Constipation—Doxorubicin—pancreatic cancer	0.000331	0.000536	CcSEcCtD
Flecainide—Abdominal pain—Epirubicin—pancreatic cancer	0.00033	0.000535	CcSEcCtD
Flecainide—Body temperature increased—Epirubicin—pancreatic cancer	0.00033	0.000535	CcSEcCtD
Flecainide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000319	0.000516	CcSEcCtD
Flecainide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000316	0.000512	CcSEcCtD
Flecainide—Urticaria—Doxorubicin—pancreatic cancer	0.000307	0.000498	CcSEcCtD
Flecainide—Body temperature increased—Doxorubicin—pancreatic cancer	0.000306	0.000495	CcSEcCtD
Flecainide—Abdominal pain—Doxorubicin—pancreatic cancer	0.000306	0.000495	CcSEcCtD
Flecainide—Asthenia—Epirubicin—pancreatic cancer	0.0003	0.000486	CcSEcCtD
Flecainide—Pruritus—Epirubicin—pancreatic cancer	0.000296	0.000479	CcSEcCtD
Flecainide—Diarrhoea—Epirubicin—pancreatic cancer	0.000286	0.000463	CcSEcCtD
Flecainide—Asthenia—Doxorubicin—pancreatic cancer	0.000277	0.00045	CcSEcCtD
Flecainide—Dizziness—Epirubicin—pancreatic cancer	0.000276	0.000448	CcSEcCtD
Flecainide—Pruritus—Doxorubicin—pancreatic cancer	0.000274	0.000443	CcSEcCtD
Flecainide—Vomiting—Epirubicin—pancreatic cancer	0.000266	0.000431	CcSEcCtD
Flecainide—Diarrhoea—Doxorubicin—pancreatic cancer	0.000265	0.000429	CcSEcCtD
Flecainide—Rash—Epirubicin—pancreatic cancer	0.000264	0.000427	CcSEcCtD
Flecainide—Dermatitis—Epirubicin—pancreatic cancer	0.000263	0.000427	CcSEcCtD
Flecainide—Headache—Epirubicin—pancreatic cancer	0.000262	0.000424	CcSEcCtD
Flecainide—Dizziness—Doxorubicin—pancreatic cancer	0.000256	0.000414	CcSEcCtD
Flecainide—Nausea—Epirubicin—pancreatic cancer	0.000248	0.000402	CcSEcCtD
Flecainide—Vomiting—Doxorubicin—pancreatic cancer	0.000246	0.000398	CcSEcCtD
Flecainide—Rash—Doxorubicin—pancreatic cancer	0.000244	0.000395	CcSEcCtD
Flecainide—Dermatitis—Doxorubicin—pancreatic cancer	0.000244	0.000395	CcSEcCtD
Flecainide—Headache—Doxorubicin—pancreatic cancer	0.000242	0.000393	CcSEcCtD
Flecainide—Nausea—Doxorubicin—pancreatic cancer	0.00023	0.000372	CcSEcCtD
